Diffuse reflectance spectroscopy for ultraviolet A protection factor measurement: Correlation studies between in vitro and in vivo measurements

Photodermatology Photoimmunology and Photomedicine

Volumn 25, Issue 6, 2009, Pages 298-304

  Ruvolo, Eduardo ^a   Chu, Melissa ^a   Grossman, Florence ^a   Cole, Curtis ^a   Kollias, Nik ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

Diffuse reflectance spectroscopy (DRS); Photostability; Round robin; UVA protection factor (PFA)

Indexed keywords

SUNSCREEN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSE REFLECTANCE SPECTROSCOPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MULTICENTER STUDY; PIGMENT DISORDER; PRIORITY JOURNAL; RADIATION PROTECTION; SKIN TEST; SPECTROFLUOROMETRY; ULTRAVIOLET A RADIATION;

HUMANS; SKIN; SPECTRUM ANALYSIS; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 73049115264     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2009.00469.x     Document Type: Article

References (40)

1. Kligman L, Akin F, Kligman A. The contributions of UVA and UVB to connective tissue damage in hairless mice. J Invest Dermatol 1985; 84: 272-276.
2. Sander CS, Chang H, Salzmann S, Müller C, Ekanayake-Mudiyanselage S, Elsner P, Thiele J. Photoaging is associated with protein oxidation in human skin in vivo. J Invest Dermatol 2002; 118: 618-625.
3. Cole C. Sunscreen protection in the ultraviolet A region: how to measure the effectiveness. Photodematol Photoimmunol Photomed 2001; 17: 2-10.
4. Cole C, Forbes PD, Davies R. An action spectrum for UV photocarcinogenesis. Photochem Photobiol 1986; 43: 275-284.
5. Weelden HV, De Gruijl FR, Van Der Leun J.C. Carcinogenesis by UVA, with an attempt to assess the carcinogenic risks of tanning with UVA and U.V.B. In: Urbach F., Gange R.W., eds. The biological effects of UVA radiation. New York: Praeger, 1986; 137-146.
6. DeGruijl FR, Forbes P.D. UV-induced skin cancer in hairless mouse model. Bioessays 1995; 17: 651-660.
7. Gilcherst B.A. A review of skin aging and its medical therapy. Br Dermatol 1996; 135: 867-875.
8. Hadshiew IM, Eller MS, Gilchrest B.A. Skin aging and photoaging: the role of DNA damage and repair. Am J Contact Dermat 2000; 11: 19-25.
9. Fisher GJ., Kang S, Varani J, Bata-Csorgo Z, Wan Y; Datta S, Voorhees J.J. Mechanisms of photoaging and chronical skin aging. Arch Dermatol 2002; 138: 1462-1470.
10. Gilchrest BA, Soter NA, Hawk JLM, Barr RM, Black AK, Hensby CN, Mallet AI, Greaves MW, Parrish J.A. Histological changes associated with ultraviolet-A-induced erythema in normal skin. J Am Acad Dermatol 1983; 9: 213-219.
11. Schwartz E, Cruickshank FA, Perlish JS, Fleischmajer R. Alterations in dermal collagen in ultraviolet irradiated hairless mice. J Invest Dermatol 1989; 93: 142-146.
12. Petersen MJ, Hansen C, Craig S. Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol 1992; 99: 440-444.
13. Young AR,Walker S.L. Effects of UVA solar simulator radiation on human immune system: influence of phototypes and wavebands. Exp Dermatol 2002; 11 (Suppl. 1): 17-19.
14. Moyal D, Fourtanier A.A.M. Effects of UVA radiation on an established immune response in humans and sunscreen efficacy. Exp Dermatol 2002; 11 (Suppl.1): 28-32.
15. Allanson M, Domanski D, Reeve V.E. Photoimmunoprotection by UVA (320-400 nm) radiation is determined by UVA dose and is associated with cutaneous cyclic guanosine monophosphate. J Invest Dermatol 2006; 126: 191-197.
16. Committee CS/42. Standards Australia, Standards New Zealand #AS/NZS 2604:1993. Sunscreen products, evaluation and classification.
17. Diffey B.L. A method for broad spectrum classification of sunscreens, Int. J Cosmet Sci 1994; 16: 47-52.
18. Boots the Chemist Ltd. The Revised Guidelines to The Practical Measurement of UVA/UVB Ratios According to the Boots Star Rating System. Nottingham, U.K. The Boots Co Plc, (2004).
19. Brown M.W. Of Cassiopeia and five stars. 2010 - A Sun Odyssey, London, June 2005.
20. Kaidbey KH, Barnes A. Determination of UVA protection factors by means of immediate pigment darkening in normal skin. J Am Acad Dermatol 1991; 2S (Part 1): 262-266.
21. Moyal D, Chardon A, Kollias N. Determination of UVA protection factors using the persistent pigment darkening (PPD) as the end point (Part 1) calibration of the method. Photodermatol Photoimmunol Photomed 2000; 16: 245-249.
22. Moyal D, Chardon A, Kollias N. UVA protection efficacy of sunscreen can be determinated by the persistent pigment darkening (PPD) method (Part 2). Photodermatol Photoimmunol Photomed 2000; 16: 250-255.
23. Stanfield J, Feldt P, Csortan E, Krochmal l. Ultraviolet sunscreen evaluations in normal subjects. J Am Acad Dermatol 1989; 20: 744-748.
24. Cole C, VanFossen R. Measurement of sunscreen UVA protection: an unsensitized human model. J Am Acad Dermatol 1992 Feb; 26: 178-184.
25. Kagetsu N, Gange RW, Parrish J.A. UVA-induced erythema, pigmentation, and skin surface temperature changes are irradiance dependent. J Invest Dermatol 1985; 85: 445-447.
26. Lowe N, Dromgoole S, Sefton J, Bourget T,Weingarten D. Indoor and outdoor efficacy testing of a broad-spectrum sunscreen against ultraviolet A radiation in psoralen-sensitized subjects. J Am Acad Dermatol 1987; 17: 224-230.
27. Kollias N, Bykowski J.L. Immediate pigment darkening thresholds of human skin to monochromatic (362 nm) ultraviolet A radiation are fluence rate dependent. Photodermatol Photoimmunol Photomed 1999; 15: 175-178.
28. Chardon A, Moyal D, Hourseeau C. Persistent pigment darkening resposne as a method for evaluation of ultraviolet A protection assays. In: Lowe NJ, Shaat NA, Pathak MA, eds. Susncreen: development, evaluation and regulatory aspects. New York: Marcel Dekker, 1997; 559-582.
29. Gillies R, Moyal D, Forestier S, Kollias N. Non-Invasive in vivo determination of UVA efficacy of sunscreens using diffuse reflectance spectroscopy. Photodermatol Photoimmunol Photomed 2003; 19: 190-194.
30. Gillies R, Kollias N. Noninvasive in vivo determination of sunscreen ultraviolet A protection factors using diffuse reflectance spectroscopy. In: Lowe N, Shaath N, Pathak M, eds. Sunscreens: development, evaluation and regulatory aspects. New York, NY: Marcel Dekker Inc., 1997; 601-608.
31. Diffey BL, Robson J. A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum. J Soc Cosmet Chem 1989; 40: 127-133.
32. Fitzpatrick TB, Pathak M, Parish J.A. Protection of human skin against the effects of the sunburn ultraviolet (290-320 nm). In: Fitzpatrick TB, et al., eds. Sunlight and man, normal and abnormal photobiological responses. Tokyo, Japan: University of Tokyo Press, 1974; 751.
33. CIE. CIE 1976 uniform colour spaces. In: Commission Internationale de l'Eclairage, ed. Colorimetry; Vol. 15. Vienna: CIE Publication, 1986; 29-32.
34. Colipa (The European Cosmetic Toiletry and Perfumery Association). COLIPA in vitro Photo protection Methods Task Force. Method for the in vitro determination of UVA protection provided by sunscreen products. Guideline 2007, 2nd edn. Brussels: COLIPA, 2007.
35. Food and Drug Administration website, www.fda.gov. PFA data available at http://www.fda.gov/ohrms/dockets/dailys/ 00/Sep00/090600/c000565_appendix_04.pdf (August 30, 2000)
36. Food and Drug Administration website, www.fda.gov. PPD data available at http://www.fda.gov/ohrms/dockets/dailys/00/ Sep00/090600/c000565_appendix_05.pdf (August 30, 2000)
37. Agin P, Cole CA, Corbett C, Sanzare C, Marenus K, Tedeshi J, Wills C. Balancing UVA and UVB protection in sunscreens: proportionality, quantitative measurement of efficacy, and clear communication to consumers. In: Shaath N, ed. Sunscreens: regulations and commercial development, 3rd edn. Boca Raton, FL: Taylor and Francis Group, Pub., 2005; 808-825.
38. Japan Cosmetic Industry Association (JCIA). Technical bulletin. Measurement standard for UVA protection efficacy. Issued November 21, 1995 and effective as of January 1, 1996.
39. Moyal D, Refregier J, Chardon A. In vivo measurement of the photostability of sunscreen products using diffuse reflectance spectroscopy. Photodermatol Photoimmunol Photomed 2002; 18: 14-22.
40. Moyal D, Wichrowski K, Tricaud C. In vivo persistent pigment darkening method: a demonstration of the reproducibility of the UVA protection factors results at several testing laboratories. Photodermatol Photoimmunol Photomed 2006; 22: 124-128.